CPHI CHINA PHARMA HOLDINGS, INC.
NYSE · SEC CIK 1106644 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 2 since 2021-09-13, latest 2023-10-19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 2
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-19 | 2023-09-29 | CPHI | Li Zhilin | CEO, Interim CFO, Dir, 10% | A - Grant | $0.14 | +13.76M | 15.14M | +996% | +$1.93M | |
| 2021-09-13 | 2021-09-09 | CPHI | Li Zhilin | CEO, Interim CFO, Dir, 10% | A - Grant | $0.67 | +1.76M | 13.81M | +15% | +$1.18M |
Purchase Sale Sale after option exercise All abbreviations